(Q45737369)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23780851%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

MicroRNA-132 suppresses autoimmune encephalomyelitis by inducing cholinergic anti-inflammation: a new Ahr-based exploration (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23780851%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23780851%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Abdullah M Alzahrani

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23780851%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Abdullah Alzahrani

series ordinal

2

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 October 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23780851%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

3 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23780851%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23780851%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23780851%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

2771-2782

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23780851%20AND%20SRC:MED&resulttype=core&format=json

Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

Modulation of Th17 development and function by activation of the aryl hydrocarbon receptor--the role of endogenous ligands.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

Aryl hydrocarbon receptor deficiency in T cells suppresses the development of collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

Aryl hydrocarbon receptor negatively regulates LPS-induced IL-6 production through suppression of histamine production in macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

The roles of aryl hydrocarbon receptor in immune responses.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

Regulation of the miR-212/132 locus by MSK1 and CREB in response to neurotrophins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

microRNA modulation of circadian-clock period and entrainment

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

NeurimmiRs: microRNAs in the neuroimmune interface.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

Acetylcholine synthesis and muscarinic receptor subtype mRNA expression in T-lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

Anti-inflammatory properties of cholinergic up-regulation: A new role for acetylcholinesterase inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

Impaired neurosteroid synthesis in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

Reciprocal actions of REST and a microRNA promote neuronal identity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

Crosstalk between the AHR signaling pathway and circadian rhythm

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

Huperzine A ameliorates experimental autoimmune encephalomyelitis via the suppression of T cell-mediated neuronal inflammation in mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

IL-6: regulator of Treg/Th17 balance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

Establishment of an interleukin 6 (IL 6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL 6 monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmine.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

An MHC anchor-substituted analog of myelin oligodendrocyte glycoprotein 35-55 induces IFN-gamma and autoantibodies in the absence of experimental autoimmune encephalomyelitis and optic neuritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

A new and rapid colorimetric determination of acetylcholinesterase activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343486

7 January 2021

Identifiers

DOI

10.1002/EJI.201343486

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23780851%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference